Ritonavir CAS 155213-67-5

Description:

Lopinavir / ritonavir have been listed in China for a long time and are mainly used in the treatment of AIDS.

The main drug of lopinavir is to combine with virus protease to make the virus particles produced immature

and non infectious; while ritonavir can inhibit the metabolism of lopinavir in liver, thus improving the

blood concentration of lopinavir and playing a synergistic role.

Specifications:

Related products:CAS 192725-17-0

Application:

This product is suitable for the treatment of human immunodeficiency virus-1 (HIV-1) infection in adults

and children over 2 years old with other antiretroviral drugs.

The experience of using lopinavir and tonavir is mainly from patients who have not received antiretroviral

therapy. Data on patients who have been treated with protease inhibitors are very limited. There are also

very limited data on remedial treatment in the case of failure of lopinavir.

Whether HIV-1 patients who have been treated with protease inhibitors choose this drug or not depends

on two factors: the results of individual virus resistance test and the treatment history.

The novel coronavirus pneumonia treatment plan (trial version third) was released in January 22, 2020,

and patients can be treated with R-B or ritonavir.

Our strengths:

We can customize according to customer’s requirement.

If you have any question pls mail us or call us.